Medicine of the Future
Sponsored by Roche and Boehringer Ingelheim
Among the opportunities arising from the COVID-19 pandemic, there is an intensification of telemedicine practices and a better acceptance of tools allowing the remote monitoring of patients. The growing use of these digital healthcare tools generates valuable health data that will fuel the development of artificial intelligence decision algorithms to optimize healthcare and better understand the health of the Quebec population. The digital transformation in health is changing the practice of health professionals, the way they interact with each other and with their patients, but also, it influences the development of large companies’ products and their ways of collaborating with the healthcare network.
The session will highlight the opportunities associated with the digital transformation in healthcare on the acceleration of business models towards the medicine of the future. It will discuss the perspectives of family medicine, the organization of health care, patients and large companies.